BR6239733D0 - Processo para preparacao de novos compostos de cefalosporina - Google Patents

Processo para preparacao de novos compostos de cefalosporina

Info

Publication number
BR6239733D0
BR6239733D0 BR139733/62A BR13973362A BR6239733D0 BR 6239733 D0 BR6239733 D0 BR 6239733D0 BR 139733/62 A BR139733/62 A BR 139733/62A BR 13973362 A BR13973362 A BR 13973362A BR 6239733 D0 BR6239733 D0 BR 6239733D0
Authority
BR
Brazil
Prior art keywords
preparation
cephalosporin compounds
new cephalosporin
new
compounds
Prior art date
Application number
BR139733/62A
Other languages
English (en)
Inventor
E Flynn
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of BR6239733D0 publication Critical patent/BR6239733D0/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/26—Methylene radicals, substituted by oxygen atoms; Lactones thereof with the 2-carboxyl group
    • C07D501/34—Methylene radicals, substituted by oxygen atoms; Lactones thereof with the 2-carboxyl group with the 7-amino radical acylated by carboxylic acids containing hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/38—Methylene radicals, substituted by nitrogen atoms; Lactams thereof with the 2-carboxyl group; Methylene radicals substituted by nitrogen-containing hetero rings attached by the ring nitrogen atom; Quaternary compounds thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/38—Methylene radicals, substituted by nitrogen atoms; Lactams thereof with the 2-carboxyl group; Methylene radicals substituted by nitrogen-containing hetero rings attached by the ring nitrogen atom; Quaternary compounds thereof
    • C07D501/46—Methylene radicals, substituted by nitrogen atoms; Lactams thereof with the 2-carboxyl group; Methylene radicals substituted by nitrogen-containing hetero rings attached by the ring nitrogen atom; Quaternary compounds thereof with the 7-amino radical acylated by carboxylic acids containing hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cephalosporin Compounds (AREA)
  • Fertilizing (AREA)
  • Shafts, Cranks, Connecting Bars, And Related Bearings (AREA)
BR139733/62A 1961-06-08 1962-06-07 Processo para preparacao de novos compostos de cefalosporina BR6239733D0 (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US11561261A 1961-06-08 1961-06-08

Publications (1)

Publication Number Publication Date
BR6239733D0 true BR6239733D0 (pt) 1973-06-14

Family

ID=22362437

Family Applications (1)

Application Number Title Priority Date Filing Date
BR139733/62A BR6239733D0 (pt) 1961-06-08 1962-06-07 Processo para preparacao de novos compostos de cefalosporina

Country Status (14)

Country Link
BE (1) BE618663A (pt)
BR (1) BR6239733D0 (pt)
CA (1) CA984379A (pt)
CH (1) CH409967A (pt)
DE (2) DE1445684A1 (pt)
DK (1) DK129199B (pt)
ES (1) ES277871A1 (pt)
FI (1) FI43597C (pt)
FR (1) FR2899M (pt)
GB (1) GB982252A (pt)
LU (1) LU41846A1 (pt)
NO (2) NO122749B (pt)
OA (1) OA02701A (pt)
SE (2) SE357204B (pt)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1082943A (en) * 1963-03-27 1967-09-13 Glaxo Lab Ltd Derivatives of 7-aminocephalosporanic acid
US3492297A (en) * 1965-07-01 1970-01-27 Merck & Co Inc Guanidino cephalosporins
GB1195203A (en) * 1966-06-24 1970-06-17 Glaxo Lab Ltd Cephalosporins

Also Published As

Publication number Publication date
NO133074C (pt) 1976-03-03
FR2899M (fr) 1964-11-09
SE322513B (pt) 1970-04-13
NO133074B (pt) 1975-11-24
FI43597C (fi) 1971-05-10
ES277871A1 (es) 1962-12-01
DK129199C (pt) 1975-01-27
OA02701A (fr) 1970-12-15
GB982252A (en) 1965-02-03
NO122749B (pt) 1971-08-09
FI43597B (pt) 1971-02-01
SE357204B (pt) 1973-06-18
DE1445684A1 (de) 1968-12-05
DE1445701A1 (de) 1969-08-28
DK129199B (da) 1974-09-09
LU41846A1 (pt) 1962-12-07
CA984379A (en) 1976-02-24
BE618663A (fr) 1962-12-14
CH409967A (de) 1966-03-31

Similar Documents

Publication Publication Date Title
BR6458616D0 (pt) Processo para preparacao de tioxanteno-sulfanamidas
BR6352419D0 (pt) Processo para a preparacao de novos compostos heterociclicos
BR6349262D0 (pt) Processo para a preparacao de compostos 2-guanidino-alcoil-1 4-benzo-dioxanicos
BR6128164D0 (pt) Aperfeicoamentos em processo para preparacao de compostos de cefalosporin
BR6572118D0 (pt) Processo para preparacao de compostos de l-aroil-aza-indolil
BR6242421D0 (pt) Processo de preparacao de compostos benzodiaze-pinicos
BR6238246D0 (pt) Processo para a preparacao de peptideos
BR6245382D0 (pt) Processo para a preparacao de derivados de tetrar-droisoquinoleina
BR6238938D0 (pt) Processo para a preparacao de compostos heterociclicos
BR6237696D0 (pt) Processo de preparacao de novos compostos de cefalosporin
BR6239733D0 (pt) Processo para preparacao de novos compostos de cefalosporina
BR6240057D0 (pt) Processo para a fabricacao de 19-nor-esteroidecetais
BR6464249D0 (pt) Processo para preparacao de novos derivados de 5-acetamino-salicilamida
BR6354971D0 (pt) Processo para fabricacao de novos compostos tiofenicos
BR6352637D0 (pt) Processo para preparacao de benzamidas
BR6238334D0 (pt) Um processo para a preparacao de compostos do cation distilbazol
BR6245605D0 (pt) Processo para a preparacao de novos compostos heterociclicos
BR6241052D0 (pt) Processo para producao de compostos heterociclicos
BR6361895D0 (pt) Processo para fabricacao de novos derivados de cefalosporina c
BR6242365D0 (pt) Processo para a preparacao de antibioticos
BR6236494D0 (pt) Processo para a preparacao de di-hidro-di-benzoxazepinas
BR6236461D0 (pt) Processo para a preparacao de di-hidro-di-benzo-xazepinas
BR6460535D0 (pt) Processo para a preparacao de di-halo-alquiltiazois
BR6240027D0 (pt) Processo para a preparacao de derivados de tetraido isoquinoleina
BR6241300D0 (pt) Processo para a preparacao de derivados de benzodiazepina